10x Genomics is trading at $82.04, up 6.16%, with no confirmed company-specific announcement or direct catalyst for the October 9 move in available coverage.
- Recent coverage points to Atera shipments and Sentira, as well as Barclays’ October 7 price-target increase; these are context, not confirmed explanations for the gain.
- The biotech ETF was modestly higher premarket, while broader indexes were also up but less than 0.5%; neither establishes a clear sector or market driver.